SCHEMBL2502185

SCHEMBL2502185

CN(C)C(=O)[C@@H]1C[C@@H](O)CN1C1(c2ccc3c(c2)OCO3)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 5/20 0.41
AVPR1B P47901 5/20 0.41
OXTR P30559 4/20 0.41
AVPR2 P30518 3/20 0.41
GPR65 Q8IYL9 1/20 0.41
BRD4 O60885 4/20 0.41
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
USP2 O75604 1/20 0.34
F2 P00734 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SCN9A Q15858 1/20 0.34
MTOR P42345 1/20 0.33
RICTOR Q6R327 1/20 0.33
RPTOR Q8N122 1/20 0.33
MAPKAP1 Q9BPZ7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2494027 0.86 AVPR1A (0.44) AVPR1AAVPR1BOXTRAVPR2GPR65
SCHEMBL2494415 0.84 AVPR1B (0.53) AVPR1AAVPR1BOXTRAVPR2GPR65
SCHEMBL2492934 0.82 AVPR1A (0.53) AVPR1AAVPR1BOXTRAVPR2GPR65
SCHEMBL5351154 0.81 AVPR1A (0.49) AVPR1AAVPR1BOXTRAVPR2GPR65
SCHEMBL2501951 0.80 AVPR1A (0.54) AVPR1AAVPR1BOXTRAVPR2GPR65
SCHEMBL2494599 0.79 AVPR1A (0.43) AVPR1AAVPR1BOXTRAVPR2GPR65
SCHEMBL2494958 0.79 AVPR1A (0.48) AVPR1AAVPR1BOXTRAVPR2GPR65
SCHEMBL2495051 0.79 AVPR1A (0.42) AVPR1AAVPR1BOXTRAVPR2GPR65
SCHEMBL2502306 0.79 AVPR1A (0.47) AVPR1AAVPR1BOXTRAVPR2GPR65
SCHEMBL2499523 0.79 AVPR1A (0.55) AVPR1AAVPR1BOXTRAVPR2GPR65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 AVPR1A 2/4885AVPR1B 1/4885OXTR 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.